These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11698143)

  • 1. On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells.
    Bogdanovic N; Bretillon L; Lund EG; Diczfalusy U; Lannfelt L; Winblad B; Russell DW; Björkhem I
    Neurosci Lett; 2001 Nov; 314(1-2):45-8. PubMed ID: 11698143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
    Kölsch H; Lütjohann D; Ludwig M; Schulte A; Ptok U; Jessen F; von Bergmann K; Rao ML; Maier W; Heun R
    Mol Psychiatry; 2002; 7(8):899-902. PubMed ID: 12232784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyp46 polymorphisms in Alzheimer's disease: a review.
    Garcia AN; Muniz MT; Souza e Silva HR; da Silva HA; Athayde-Junior L
    J Mol Neurosci; 2009 Nov; 39(3):342-5. PubMed ID: 19705089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.
    Kölsch H; Lütjohann D; Jessen F; Popp J; Hentschel F; Kelemen P; Schmitz S; Maier W; Heun R
    Eur Psychiatry; 2009 Apr; 24(3):183-90. PubMed ID: 19286353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease.
    Desai P; DeKosky ST; Kamboh MI
    Neurosci Lett; 2002 Aug; 328(1):9-12. PubMed ID: 12123847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
    Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
    Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease.
    Tian G; Kong Q; Lai L; Ray-Chaudhury A; Lin CL
    J Neurochem; 2010 May; 113(4):978-89. PubMed ID: 20193040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
    Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
    Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms.
    Vega GL; Weiner MF
    J Mol Neurosci; 2007 Sep; 33(1):51-5. PubMed ID: 17901546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
    Lütjohann D; von Bergmann K
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease.
    Reiss AB; Siller KA; Rahman MM; Chan ES; Ghiso J; de Leon MJ
    Neurobiol Aging; 2004 Sep; 25(8):977-89. PubMed ID: 15212822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
    Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
    Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association of CYP46 and risk for Alzheimer's disease.
    Combarros O; Infante J; Llorca J; Berciano J
    Dement Geriatr Cogn Disord; 2004; 18(3-4):257-60. PubMed ID: 15286456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease.
    Ingelsson M; Jesneck J; Irizarry MC; Hyman BT; Rebeck GW
    Neurosci Lett; 2004 Sep; 367(2):228-31. PubMed ID: 15331159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of cholesterol hydroxylases in Alzheimer's disease.
    Brown J; Theisler C; Silberman S; Magnuson D; Gottardi-Littell N; Lee JM; Yager D; Crowley J; Sambamurti K; Rahman MM; Reiss AB; Eckman CB; Wolozin B
    J Biol Chem; 2004 Aug; 279(33):34674-81. PubMed ID: 15148325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury.
    Cartagena CM; Burns MP; Rebeck GW
    Brain Res; 2010 Mar; 1319():1-12. PubMed ID: 20053345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain.
    Cartagena CM; Ahmed F; Burns MP; Pajoohesh-Ganji A; Pak DT; Faden AI; Rebeck GW
    J Neurotrauma; 2008 Sep; 25(9):1087-98. PubMed ID: 18729719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population.
    Kabbara A; Payet N; Cottel D; Frigard B; Amouyel P; Lambert JC
    Neurosci Lett; 2004 Jun; 363(2):139-43. PubMed ID: 15172102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.